AbbVie Newsroom

AbbVie Inc. (NYSE:ABBV) Is Favoured by Institutional Owners Who Hold 73% of the Company

Simply Wall StSep 1 08:32 ET

Investors in AbbVie (NYSE:ABBV) Have Seen Solid Returns of 262% Over the Past Five Years

Yahoo FinanceAug 31 07:00 ET

AbbVie Options Trading: A Deep Dive Into Market Sentiment

BenzingaAug 29 15:31 ET

Piper Ups Neurocrine to Overweight, Says '568 Still in the Game

Seeking AlphaAug 29 10:30 ET

AbbVie Inc. (ABBV) Is Attracting Investor Attention: Here Is What You Should Know

Zacks Aug 29 08:15 ET

New Medicare Drug Price Caps Could Help Seniors Save Over $1,000 a Year - AARP

Seeking AlphaAug 29 06:26 ET

As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors

BenzingaAug 28 11:16 ET

Express News | Abbvie : Leerink Partners Raises Target Price to $206 From $196

ReutersAug 28 06:03 ET

Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna

BenzingaAug 27 15:22 ET

AbbVie Awards Scholarships to 45 U.S. Students Living With Chronic Immune-Mediated Diseases

PR NewswireAug 27 08:15 ET

SkinMedica Revolutionizes Skin Hydration With the Introduction of HA5 Hydra Collagen Replenish + Restore Hydrator

newsfilter.ioAug 27 08:05 ET

Study Results From Phase 1 Studies With Exidavnemab Published in The Journal of Clinical Pharmacology

PR NewswireAug 27 02:27 ET

Unusual Options Activity: ABBV, KHC and Others Attract Market Bets, ABBV V/OI Ratio Reaches 42.3

Moomoo NewsAug 26 16:30 ET

AbbVie Unusual Options Activity For August 26

BenzingaAug 26 14:15 ET

Evercore ISI Raises Price Target on AbbVie to $192 From $180, Keeps Outperform Rating

MT NewswiresAug 26 07:11 ET · Ratings

Is the rebound fading? Goldman Sachs: Hedge funds are selling stocks at the fastest pace in more than two years.

In August, 'smart money' is selling global equities at the fastest pace since March 2022, with the most net selling in North America. Hedge funds are skeptical of the sustainability of the stock market rebound, and geopolitical concerns continue to be worrying. The 'fly' of the economic situation may soon hit the glass windshield.

wallstreetcnAug 26 03:22 ET

Should You Be Excited About AbbVie Inc.'s (NYSE:ABBV) 78% Return On Equity?

Yahoo FinanceAug 25 09:00 ET

Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets

BenzingaAug 23 14:21 ET

AbbVie Analyst Ratings

BenzingaAug 23 10:23 ET · Ratings

Piper Sandler Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $209

Moomoo NewsAug 23 07:31 ET · Ratings